MENS Latest Press Releases

-- May 29, 2026 --

Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview Globe Newswire 8:00 AM

-- May 15, 2026 --

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 Globe Newswire 8:30 AM

-- April 28, 2026 --

Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio Globe Newswire 8:30 AM

-- March 27, 2026 --

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS-2 Globe Newswire 8:30 AM

-- February 12, 2026 --

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia Globe Newswire 8:30 AM

-- January 30, 2026 --

Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-8 (PCP), Indicating Potential in Prostate Cancer Prevention and Metabolic Value Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software